Evidence map›Paper›PMID 37703121›Full record

ArticleSao Paulo medical journal = Revista paulista de medicina2023

Drug use among medical students in São Paulo, Brazil: a cross-sectional study during the coronavirus disease 2019 pandemic.

Pedro Lemos-Santos, Lukas Blumrich, Jordi Blanes Debia, João Mauricio Castaldelli-Maia, Paulo Jeng Chian Suen, André Malbergier

Abstract read
In one paragraph

Article in Sao Paulo medical journal = Revista paulista de medicina, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pedro Lemos-SantosUndergraduate Student, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil.ORCID 0000-0003-1738-1359
Lukas BlumrichUndergraduate Student, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil; Doctoral Student, Department of Pediatrics, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil.ORCID 0000-0001-5219-3949
Jordi Blanes DebiaUndergraduate Student, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil.ORCID 0000-0001-8168-064X
João Mauricio Castaldelli-MaiaPhD, Postgraduate Sponsor, Department of Psychiatry, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil; Assistant (Aux.) Professor, Department of Neuroscience, Centro Universitário Faculdade de Medicina do ABC (FMABC), Santo André (SP), Brazil.ORCID 0000-0001-9621-2291
Paulo Jeng Chian SuenUndergraduate Student, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil; Doctoral Student, Department of Psychiatry, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil.ORCID 0000-0002-7806-6603
André MalbergierPhD, General Coordinator, Interdisciplinary Group of Studies on Alcohol and Drugs (GREA), Institute of Psychiatry (IPq), Hospital das Clínicas da Universidade de São Paulo (HCFMUSP), São Paulo (SP), Brazil; Collaborating Professor, Department of Psychiatry, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil.ORCID 0000-0001-6093-8381

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedical students demonstrate higher rates of substance use than other university students and the general population. The challenges imposed by the coronavirus disease 2019 (COVID-19) pandemic raised significant concerns about mental health and substance use.

objectivesAssess the current prevalence of substance use among medical students at the University of São Paulo and evaluate the impact of the COVID-19 pandemic on drug consumption. DESIGN AND

settingA cross-sectional study was conducted on 275 medical students from the University of São Paulo Medical School (São Paulo, Brazil) in August 2020.

methodsSubstance use (lifetime, previous 12 months, and frequency of use before and during the COVID-19 pandemic) and socioeconomic data were assessed using an online self-administered questionnaire. Symptoms of depression were assessed using the Patient Health Questionnaire-9.

resultsAlcohol was the most consumed substance in their lifetime (95.6%), followed by illicit drugs (61.1%), marijuana (60%), and tobacco (57.5%). The most commonly consumed substances in the previous year were alcohol (82.9%), illicit drugs (44.7%), marijuana (42.5%), and tobacco (36%). Students in the first two academic years consumed fewer substances than those from higher years. There was a decreasing trend in the prevalence of most substances used after the COVID-19 pandemic among sporadic users. However, frequent users maintained their drug use patterns.

conclusionThe prevalence of substance use was high in this population and increased from the basic to the clinical cycle. The COVID-19 pandemic may have affected the frequency of drug use and prevalence estimates.

Indexed as

COVID-19Illicit DrugsStudents, MedicalSubstance-Related DisordersBrazilCross-Sectional StudiesEthanolHumansPandemicsEthanolIllicit Drugs

Identifiers

PMID37703121
PMCPMC10495101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.